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EDITORIAL
Plasma aldosterone regulation in anephric man
The major role of the kidney in the regulation of aldo-
sterone secretion is well-established [1—3]. The kidneys'
dominance in controlling aldosterone output is mediated
via the renin-angiotensin system which is remarkably
responsive to changes in sodium intake as well as changes
in body posture [4—9]. The majority of available evidence
indicates that this pathway serves as the primary mechanism
for the regulation of sodium balance in virtually all mam-
malian species [10]. Other factors stimulating aldosterone
production include ACTH and changes in [Na] and [K]
in the plasma [11—16]. Their role in the physiologic re-
gulation of aldosterone secretion by the adrenal has been
less well defined, due in large part to the predominance of
the kidneys' role. This has required that these other factors
be studied in nephrectomized animals during acute short-
term experiments following extensive surgery, including
bilateral nephrectomy. The physiological significance of
such studies must be accepted with some reservation. De-
spite this, some of these studies have raised the question as
to whether significant regulatory mechanisms may exist
that are independent of the kidney and the renin-angiotensin
system [17, 18]. The anephric human maintained on hemo-
dialysis has afforded the opportunity to examine some of
these factors under more stable and physiologic conditions
that assure absence of interference from an intact renin-
angiotensin system. It should, under such circumstances,
be possible to look more carefully at the question of alter-
native means of aldosterone regulation exclusive of the
renin-angiotensin system.
Among the unsettled questions that may be examined in
the context of an anephric subject are the following:
1) to what extent do other mechanisms merely modulate
the activity of the renin-angiotensin system and to what
extent do they independently influence aldosterone se-
cretion? 2) if they exist as independent mechanisms, what
are the initiating stimuli and what purposes do they serve?
3) are there unrecognized stimuli or mechanisms re-
sponsible for initiating and/or maintaining aldosterone
production? 4) lastly, and perhaps most importantly from
the standpoint of understanding the physiology of the
anephric individual, is there a physiologic need for a!-
dosterone; what useful purpose does it serve in the absence
of the kidneys?
Answers to most of these questions are either unavailable
or can only be formulated in incomplete fashion from
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currently available information. However, recent infor-
mation from studies in anephric patients on hemodialysis
makes it appropriate to review the present information
bearing on these questions to see whether more complete
answers may be obtained from further study of the anephric
state.
ACTH effects. Prior to the observations of Genest et al
[19] and Laragh et al [20] that focused subsequent in-
vestigative efforts on the kidney as the seat of aldosterone
regulation, it was established that ACTH administration
stimulated aldosterone secretion [11, 12, 21]. Although
much experimental work has established a role for ACTH
in the regulation of aldosterone secretion, the precise
mechanism whereby this effect is exerted remains unclear.
Presently available evidence is most consistent with the
concept that ACTH plays a supportive role (production of
precursors for aldosterone) while the renin-angiotensin
system provides the direct stimulation of aldosterone
production [10]. Thus, the maximal aldosterone stimulating
effect of the renin-angiotensin system appears to depend
upon a concomitantly adequate output of ACTH [22]. In
support of this view, aldosterone secretion following blood
loss is known to be less in the hypophysectomized dog than
in the normal dog [22, 23].
If the role of ACTH is only supportive, the anephric
patient on hemodialysis should show no response in aldo-
sterone production when ACTH is administered. The
results of such studies have yielded conflicting results. Some
investigators report little or no response to ACTH ad-
ministration [18, 24, 251, while others describe a significant
increase of production [26, 32]. Differences in the reported
results are too large to be explained by methodologic
variation. Further studies are clearly necessary. It has been
suggested that volume depletion sensitizes the zona gb-
merulosa to ACTH in the anephric state [26], but data
showing an increase in plasma aldosterone in response to
ACTH in anephric subjects in an expanded state have also
been reported [32]. Additional study of this problem in
which aldosterone responsiveness to ACTH is examined as
a function of ECF or plasma volume, and circulating [K]
and [Na] should provide clearer definition of the factors
that modulate the response of aldosterone to ACTH in-
fusion, thus clarifying the role of ACTH in aldosterone
regulation in the absence of the renin-angiotensin system.
The importance of carefully establishing the role of ACTH
in anephric subjects is paramount since demonstration of
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a direct role for ACTH in the absence of kidneys may offer
a possible explanation for some of the discrepancies in the
results of similarly designed studies in these individuals
(see below).
Non-renal sodium effects. The primary mechanism by
which aldosterone responds to alterations in sodium is
provided by the renin-angiotensin system. The primacy of
this control mechanism has been clearly established in both
normal and pathologic conditions. Whether the sodium
has alternate stimulatory access to the adrenal gland by
some mechanism that excludes the renin-angiotensin system
is less certain. Some acute animal experiments suggest that
the zona glomerulosa responds directly to lowered [Na]
with increased aldosterone secretion [27] but such obser-
vations have usually been made in situations in which
blood perfusing the adrenal gland had altered the concen-
trations of both sodium and potassium [13, 28], although
some studies suggest that the lowered [Na] alone augments
aldosterone output [15, 27]. It seems unlikely that this is
an important mechanism in the human; in fact, marked
suppression of aldosterone secretion in the syndrome of
inappropriate secretion of antidiuretic hormone has been
demonstrated even when the serum sodium concentration
was as low as 115 mEq/liter [29]. That these patients were
capable of responding with an adequate aldosterone output
was proven by demonstrating that they subsequently
responded normally to sodium deprivation with an in-
creased aldosterone output when the extra water was
excreted and the plasma [Na] had returned to normal values
[30]. These observations indicate that, in the human, volume
expansion (even when induced by water administration or
retention and leading to hypotonicity) is a much more
potent suppressing stimulus than is hyponatremia a stimulus
for increased aldosterone production. Thus, a primary
sodium stimulating mechanism independent of the renin-
angiotensin system is either of little physiological signi-
ficance or non-existent in the human.
Studies from our laboratory in anephric individuals tend
to support the view that no sodium-activated mechanism
exists that is independent of the renin-angiotensin system
[31]. When observations on plasma aldosterone were made
in a group of anephric patients maintained in the supine
position and studied on the first, third and fourth post-
dialysis days, plasma aldosterone was shown to rise more
than tenfold from 1.1 to 13.3 ng/100 ml of plasma despite
sodium retention during the interval as indicated by a mean
weight gain of 1.05 kg. Similarly, no correlation between
serum [Na] and plasma aldosterone could be demonstrated
in these studies. We thus obtained no evidence that al-
dosterone was influenced by sodium in the anephric indi-
vidual [31].
Results of other investigators have not always confirmed
these findings. Several studies have reported similar find-
ings [24, 25] but Mitra et al [32] could find no evidence for
increased plasma aldosterone when anephric patients were
volume depleted by peritoneal dialysis. These authors did
record a decrease in plasma aldosterone concentration with
subsequent volume expansion by means of an infusion of
isotonic saline. However, the design of these latter ex-
periments was such that alterations in metabolic clearance
rate may have conspired to create the impression that this
was a volume response. The patients had previously been
standing and experienced difficulty with postural hypo-
tension. The reduction in hepatic blood flow and metabolic
clearance associated with hypotension could account, at
least in part, for the observed increase in plasma aldosterone
while the subjects were standing [33, 34]. Infusion of saline
concomitantly with resumption of the supine position thus
provides two stimuli that could influence the plasma al-
dosterone concentration; hence, clear interpretation of the
results is not possible. Of more importance to the inter-
pretation of their results is the possible role of ACTH in
aldosterone production in the anephric state. No data are
presently available on plasma ACTH levels in anephric
subjects, so that it is only possible to make inferences from
fluctuations in plasma cortisol levels [23]. In this context,
it is of interest that they recorded a 50% increase in plasma
cortisol concentration after two hours of quiet standing,
with a subsequent reduction to the previous supine values
when the subjects were returned to the supine position and
infused with saline. In contrast, the changes which we
observed were noted in the absence of significant changes
in plasma corticoids [31]. The most plausible explanation
for this difference is the differing activity in the two groups
while standing. Their subjects stood quietly and experienced
difficulty with postural hypotens ion; our patients ambu-
lated slowly and were asymptomatic during the upright
period. It is thus possible that postural hypotension could
have resulted in ACTH release with a consequent increase
in plasma corticoids and aldosterone. The uncertainties in
interpretation of presently available data on anephric
subjects further emphasize the necessity of a clearer de-
finition of the role of ACTH in aldosterone regulation by
anephric man. At present, changes in ACTH release and
metabolic clearance rate would seem to provide plausible
explanations for the disparate results of different investi-
gators who have studied the response to volume changes in
anephric subjects [26, 33, 44]. Weidman et al [25], Boyd
and associates [18, 24], and ourselves [31] have all failed to
find an inverse relation between changes in volume and
changes in plasma aldosterone concentrations in anephric
man, as contrasted with the results of Liddle, Duncan and
Bartter [12]. Thus, there is not yet convincing evidence that
changes in sodium balance effect a response in anephric
man that is analogous to that reported in the anephric rat
by Palmore, Marieb and Mulrow [35].
Posture. Studies of the effects of posture on plasma
aldosterone have yielded conflicting data similar to those
considered above. Several groups have failed to detect
significant changes [24, 31, 33, 45], while others have re-
ported variable results [25] or a regular increase with
assumption of the upright posture [321. For reasons cited
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above, the possibility that an observed increase in the up-
right posture is due to some combination of decreased
metabolic clearance rate, ACTH release, and/or changes in
plasma [K] cannot be excluded. Our observations in the
early post-dialysis period showed very low values for plasma
aldosterone with no change in the upright position after two
hours of ambulation (supine 1.6 0.3, upright 2.0 0.5 ng
aldosterone per 100 ml plasma). On the third or fourth day
post-dialysis, the mean values did not differ significantly
between supine and upright positions (supine 12.5 4.2;
upright 12.6 6.1 ng/l 00 ml), but several individual sub-
jects showed large changes. In each instance these were
associated with concordant changes in plasma [K]. Thus, the
majority of the present evidence is consistent with the view
that changes in the response to posture are not seen in the
anephric individual except in the presence of coincidental
stimuli such as changes in plasma [K], ACTH release or
metabolic clearance rate. Further studies are necessary,
however, to clearly define the role of these latter two in-
fluences in the anephric patient.
Potassium. The role of potassium in the modulation of
aldosterone secretion has been well established, although
most early studies were done in intact subjects or experi-
mental animals with a functioning renin-angiotensin
system [37—39]. Laragh and Stoerk [40], however, suggested
that plasma [K] stimulated the adrenal directly to produce
aldosterone, and Denton, Goding and Wright [13] provided
supporting evidence for this view from studies in an in vitro
preparation. Numerous investigators [16, 27, 41] have con-
firmed this observation using different experimental ap-
proaches in several species. Baumber et al [42] have de-
monstrated that potassium administration, which serves to
increase aldosterone output, also increases the [K] content
of the adrenal gland. Burwell, Davis and Bartter [41], from
in vitro studies suggested that K acts to facilitate conversion
of deoxycorticosterone to corticosterone.
These studies all identify an aldosterone-stimulating role
for potassium that does not appear to involve the kidney.
The predominant view to date, however, is that this is of
little, if any physiologic significance in the intact animal
[10], but there is no uniform agreement on this point [16].
Recent observations in anephric patients assign a prominent
role to potassium in aldosterone production in the absence
of kidneys.
In contrast with the sodium effect on aldosterone pro-
duction which vanishes with removal of kidneys, a highly
significant correlation can be demonstrated between po-
tassium and aldosterone concentrations in the plasma of
anephric individuals [31]. Within a single individual these
changes are even more closely correlated. In a series of
studies examining the relation of posture, volume changes
and changes in plasma composition to plasma aldosterone
levels in anephric patients, it has only been possible to
identify an association between changes in plasma [K]
and changes in plasma aldosterone. Not only is an increase
in [K] associated with an increase in aldosterone, but, con-
versely, in those individuals exhibiting a decrease in plasma
[K] between serial observations, aldosterone also decreases
as well. A report on the influence of changes in concentra-
tion of K in the dialysate upon plasma aldosterone con-
centration is consistent with these findings [25].
The precise mechanism whereby potassium exerts its
influence upon aldosterone secretion cannot be inferred
from these data. It is possible that changes in plasma [K]
reflect changes in intracellular potassium and that intra-
cellular K within the adrenal is the real determinant of
plasma aldosterone levels in the anephric state. Studies
cited [41, 42] would indicate that intracellular [K] is the
more likely regulatory concentration. If so, then it may be
expected that procedures that lower [K] by stimulating
movement of potassium into cells would increase aldo-
sterone output despite a decrease in plasma concentration.
Adequate data are not available on this point, but several
subjects have been observed in whom decreases in plasma
[K] (unassociated with dialysis) must have represented
movement of K into some cells within the body. In these
subjects the lowered [K] was associated with a decreased
plasma aldosterone. This could only be reconciled with the
above view that intracellular K within the adrenal is of
prime significance in the regulation of aldosterone secretion
if such decreases in plasma [K] represents entrance of K
selectively into other cells such as the liver, while K within
the adrenal continues to decrease. This question requires
further study and probably can be answered only by appro-
priately designed animal experiments.
Otheè stimuli. Studies in anephric individuals have thus
far provided useful information on the role of potassium
in the regulation of plasma aldosterone, and the variable
responses to ACTH suggest that further study of the
anephric subject will permit a clearer definition of the role
of ACTH in aldosterone regulation. Convincing evidence
of a new and previously undefined regulatory mechanism
has not yet been forthcoming. In fact, it may be premature to
consider the question of additional regulatory mechanisms
or stimuli before further defining the physiologic responses
to known stimuli for aldosterone production in the anephric
state, as well as the alterations in aldosterone metabolism
that may arise therefrom. One serious shortcoming of the
available studies is a lack of information about aldosterone
secretory rates in the absence of the kidneys. A decreased
capacity for conjugation or degradation resulting from loss
of the kidneys and/or hepatic impairment secondary to
uremia could lead to a progressive increase in plasma aldo-
sterone in the absence of any increase in activity of the
zona glomerulosa. The progressive increase in plasma aldo-
sterone between dialyses in our studies, as well as those of
others, could thus be explained in part in this fashion. It
is also evident that such an explanation could well be
provided by the significant correlation between changes of
plasma [K] and aldosterone since plasma [K] also rises
between dialyses. The strongest arguments against this as a
satisfactory explanation for the observed correlation are the
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results of the K depletion studies in which a rise of plasma
aldosterone was prevented [311, and the association between
a decreased plasma [K] and decreased plasma aldosterone
in the absence of dialysis. Thus, while stimuli have been
shown to alter plasma aldosterone in anephric humans, it is
not possible to compare these responses with those seen in
normal humans without further information on secretory
rates and the metabolic clearance of aldosterone in the
anephric patient. At this relatively early stage in the evo-
lution of our knowledge of aldosterone physiology in the
anephric state, it is hazardous to attribute unexpected
responses to new or previously unrecognized stimuli.
The question of whether changes in aldosterone have any
physiologic significance in the absence of the kidney cannot
be answered with certainty at present. The observations of
Hayes, McLeod and Robinson [43] that fractional fecal K
excretion increases in chronic renal failure, and that this
represents a significant route of K excretion (up to 75 % of
ingested K) in uremia, would suggest that the persistence
of the potassium stimulus for aldosterone secretion in the
anephric state may serve a useful physiologic purpose in
these patients. The unexpected finding, in our studies, of
marked fluctuations of plasma [K] in association with
postural changes and ambulation in patients who have not
been dialysed for several days and hence have a surfeit of
potassium, further emphasizes the potential importance of
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